Skip to main content

Table 2 Socio-demographic characteristics at baseline

From: Impact of a combined multimodal-aerobic and multimodal intervention compared to standard aerobic treatment in breast cancer survivors with chronic cancer-related fatigue - results of a three-armed pragmatic trial in a comprehensive cohort design

Treatment group Aerobic treatment Multimodal treatment Combination treatment p-value
Included 28 44 54  
Started Intervention T0 20 34 51  
Completed T1 13 30 41  
Marital status
 Single (%) 1 (5.00) 7 (20.59) 8 (15.69) 0.5994
 Married (%) 14 (70.00) 16 (47.06) 27 (52.94)
 Divorced (%) 3 (15.00) 8 (23.53) 13 (25.49)
 Widowed (%) 2 (10.00) 2 (5.88) 2 (3.92)
 Missing data (%) 0 (0.00) 1 (2.94) 1 (1.96)
Children: yes (%)/ Children at home: yes (%) 16 (80.00)/ 6 (30.00) 23 (67.65)/ 8 (23.53) 38 (74.51)/ 11 (21.57) 0.3481/ 0.6599
Employment
 Employed (%) 9 (45.00) 10 (29.41) 25 (49.02) 0.1242
 Housewife (%) 1 (5.00) 3 (8.82) 1 (1.96)
 Unemployed (%) 0 (0.00) 1 (2.94) 6 (11.76)
 Pensioner (%) 6 (30.00) 13 (38.24) 11 (21.57)
 Sickness certificate (%) 3 (15.00) 4 (11.76) 4 (7.84)
 Other (%) 0 (0.00) 2 (5.88) 1 (1.96)
 Missing data (%) 1 (5.00) 1 (2.94) 3 (5.88)
Vocational education
 Apprenticeship (%) 9 (45.00) 13 (38.24) 20 (39.22) 0.2138
 Technical College (%) 4 (20.00) 3 (8.82) 3 (5.88)
 University of Applied Sciences (%) 3 (15.00) 2 (5.88) 4 (7.84)
 University (%) 0 (0,00) 9 (26.47) 12 (23.53)
 No (%) 0 (0.00) 1 (2.94) 1 (1.96)
 Missing data (%) 4 (20.00) 6 (17.65) 11 (21.57)
Age: Mean (SD) 59.8 (9.8) 60.3 (9.5) 56.6 (7.9) 0.1460
Years since first diagnosis: Mean (SD) 1.9 (0.9) 2.2 (0.8) 1.9 (0.8) 0.1273
Surgery: yes/ % 20/ 100.0 34/ 100.0 51/ 100.0  
Chemotherapy: yes/ % 12/ 60.00 22/ 64.71 19/ 37.25 0.0501
Years since chemotherapy: Mean (SD) 2.1 (0.7) 1.6 (0.6) 1.8 (0.7) 0.1372
Radiotherapy: yes/ % 14/ 70.00 29/ 85.29 38/ 74.51 0.6000
Antihormonal therapy: yes/ % 17/ 85.00 23/ 67.65 32/ 62.75 0.4947
Mistletoe therapy: yes/ % 6/ 30.00 7/ 20.59 13/ 25.49 0.6797
  1. Numbers and percentages concerning patients which started the intervention (T0)